ENVERIC BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
ENVERIC BIOSCIENCES, INC. (ENVB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 762.70 thousand shares for the 12-month period ending 2016-12-31, per its 10-K/A filed 2017-04-04.
Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2017-04-04
- ENVERIC BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-12-31 was 679.51K shares.
- ENVERIC BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-09-30 was 0.00 shares.
- ENVERIC BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2016-03-31 was 83.19K shares, a 20.77% decline year-over-year.
- ENVERIC BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 762.70K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2016-12-31 | 679.51K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-04-04 | 679.51K shares derived: sum of 2 quarters · filed 2017-04-04 | 679.51K shares derived: sum of 3 quarters · filed 2017-04-04 | 762.70K shares 10-K/A · filed 2017-04-04 |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2016-11-14 | 83.19K shares 10-Q · filed 2016-11-14 | |
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | 83.19K shares 10-Q · filed 2016-08-12 | ||
| 2016-03-31 | 83.19K shares 10-Q · filed 2016-05-16 | |||
| 2015-12-31 | 83.19K shares 10-KT · filed 2016-03-15 | |||
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | 650.50K shares derived: sum of 2 quarters · filed 2016-11-14 | 755.50K shares 10-Q · filed 2016-11-14 | |
| 2015-06-30 | 650.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | 755.50K shares 10-Q · filed 2016-08-12 | ||
| 2015-03-31 | 105.00K shares 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |